ArchPoint Investors’s Recursion Pharmaceuticals RXRX Stock Holding History

ArchPoint Investors’s Portfolio RXRX Stock Details RXRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell
2023 Q3	$8.01M	Sell
2023 Q2	$8.33M	Hold
2023 Q1	$7.43M	Hold
2022 Q4	$8.59M	Sell
2022 Q3	$11.9M	Sell
2022 Q2	$10.3M	Hold
2022 Q1	$9.07M	Buy
2021 Q4	$21.5M	Buy